110 related articles for article (PubMed ID: 36100258)
1. Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
Varelas C; Gavriilaki E; Sakellari I; Klonizakis F; Anagnostopoulos A; Tsapas A; Vlachaki E
Hemoglobin; 2022 Mar; 46(2):143-145. PubMed ID: 36100258
[TBL] [Abstract][Full Text] [Related]
2. Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.
Taher AT; Bou-Fakhredin R; Kreidieh F; Motta I; De Franceschi L; Cappellini MD
Am J Hematol; 2020 Aug; 95(8):E208-E210. PubMed ID: 32394480
[No Abstract] [Full Text] [Related]
3. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
[TBL] [Abstract][Full Text] [Related]
4. Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
Haghpanah S; Hosseini-Bensenjan M; Sayadi M; Karimi M
Hemoglobin; 2021 Nov; 45(6):371-379. PubMed ID: 34027786
[TBL] [Abstract][Full Text] [Related]
5. Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
Longo F; Gianesin B; Voi V; Motta I; Pinto VM; Piolatto A; Spasiano A; Ruffo GB; Gamberini MR; Barella S; Mariani R; Fidone C; Rosso R; Casale M; Roberti D; Dal Zotto C; Vitucci A; Bonetti F; Pitrolo L; Quaresima M; Ribersani M; Quota A; Arcioni F; Campisi S; Massa A; De Michele E; Lisi R; Miano M; Bagnato S; Gentile M; Carrai V; Putti MC; Serra M; Gaglioti C; Migone De Amicis M; Graziadei G; De Giovanni A; Ricchi P; Balocco M; Quintino S; Borsellino Z; Fortini M; Denotti AR; Tartaglione I; Beccaria A; Marziali M; Maggio A; Perrotta S; Piperno A; Filosa A; Cappellini MD; De Franceschi L; Piga A; Forni GL
Am J Hematol; 2022 Feb; 97(2):E75-E78. PubMed ID: 34861054
[No Abstract] [Full Text] [Related]
6. Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race.
Frediani JK; Pak-Harvey E; Parsons R; Westbrook AL; O'Sick W; Martin GS; Lam WA; Levy JM
Blood Cells Mol Dis; 2023 Sep; 102():102756. PubMed ID: 37257234
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Sinopharm Vaccine for SARS-CoV-2 and breakthrough infections in Iranian Patients with Hemoglobinopathies: A Preliminary Report.
Karimi M; Zarei T; Haghpanah S; Azarkeivan A; Naderi M; Matin S; Bazrafshan A; Zahedi Z; Shirkavand A; Pishdad P; De Sanctis V
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022026. PubMed ID: 35444764
[TBL] [Abstract][Full Text] [Related]
8. From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies.
Oliveira CM; Soares VJ; Rechenmacher C; Daudt LE; Michalowski MB
Clinics (Sao Paulo); 2022; 77():100004. PubMed ID: 35113785
[TBL] [Abstract][Full Text] [Related]
9. Work place and prevalence of COVID-19 in a rural population in Greece.
Papagiannis D; Kotsiou OS; Fradelos EC; Perlepe G; Miziou A; Siachpazidou DS; Gourgoulianis KI
Rural Remote Health; 2022 Jul; 22(3):6751. PubMed ID: 35853536
[TBL] [Abstract][Full Text] [Related]
10. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.
Canatan D; De Sanctis V
Acta Biomed; 2020 May; 91(2):218-221. PubMed ID: 32420950
[No Abstract] [Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. A bulletin from Greece: a health system under the pressure of the second COVID-19 wave.
Siettos C; Anastassopoulou C; Tsiamis C; Vrioni G; Tsakris A
Pathog Glob Health; 2021 May; 115(3):133-134. PubMed ID: 33533705
[TBL] [Abstract][Full Text] [Related]
13. Thalassemias and hemoglobinopathies in Turkey.
Canatan D
Hemoglobin; 2014; 38(5):305-7. PubMed ID: 25030194
[TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of hemoglobinopathies and thalassemias in individuals referred to the haematology research centre, Shiraz University of Medical Sciences, Shiraz, Iran from 2006 to 2011.
Haghpanah S; Ramzi M; Zakerinia M; Nourani Khojasteh H; Haghshenas M; Rezaei N; Moayed V; Rezaei A; Karimi M
Hemoglobin; 2014; 38(4):287-8. PubMed ID: 24941048
[TBL] [Abstract][Full Text] [Related]
16. Micromapping of Thalassemia and Hemoglobinopathies Among Laos, Khmer, Suay and Yer Ethnic Groups Residing in Lower Northeastern Thailand.
Bunthupanich R; Karnpean R; Pinyachat A; Jiambunsri N; Prakobkaew N; Pakdee N; Fucharoen S; Fucharoen S
Hemoglobin; 2020 May; 44(3):162-167. PubMed ID: 32586159
[TBL] [Abstract][Full Text] [Related]
17. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
18. The interactions of alpha-thalassemia with hemoglobinopathies.
Steinberg MH
Hematol Oncol Clin North Am; 1991 Jun; 5(3):453-73. PubMed ID: 1864819
[TBL] [Abstract][Full Text] [Related]
19. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
20. Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
Rodriguez-Capote K; Higgins TN
Clin Biochem; 2015 Jul; 48(10-11):698-702. PubMed ID: 25869492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
